Bioequivalence Study of Two Formulations of Atorvastatin Film-coated Tablets 40 mg in Healthy Volunteers Under Fasting Conditions
Condition: Bioequivalence Intervention: Drug: Atorvastatin film-coated tablet 40 mg / Liprimar® film-coated tablet 40 mg Sponsors: Pharmtechnology LLC; ClinPharmInvest, LLC Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials